Emerging roles of Aurora-A kinase in cancer therapy resistance
Acta Pharmaceutica Sinica B · 2023-07 · 13 (7) · 2826-2843
DOI: 10.1016/j.apsb.2023.03.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-07. Verfasst von Dayong Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China.
- Basic Medical Science College, Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China.
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
- Department of Oncology and Cancer Therapeutics Program, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Zitieren
APA
Zheng, D., Li, J., Yan, H., Zhang, G., Li, W., Chu, E., & Wei, N. (2023). Emerging roles of Aurora-A kinase in cancer therapy resistance. Acta Pharmaceutica Sinica B, 13(7), 2826-2843. https://doi.org/10.1016/j.apsb.2023.03.013
Vancouver
Zheng D, Li J, Yan H, Zhang G, Li W, Chu E, et al. Emerging roles of Aurora-A kinase in cancer therapy resistance. Acta Pharmaceutica Sinica B. 2023;13(7):2826-2843. doi:10.1016/j.apsb.2023.03.013
BibTeX
@article{Zheng2023,
author = {Zheng, Dayong and Li, Jun and Yan, Han and Zhang, Gang and Li, Wei and Chu, Edward and Wei, Ning},
title = {Emerging roles of Aurora-A kinase in cancer therapy resistance},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {7},
pages = {2826--2843},
doi = {10.1016/j.apsb.2023.03.013}
}
EUVIMED